Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus (Q40123387)

17 September 2017

title

Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus (English)

1 reference

17 September 2017

1 reference

vaccinia virus

1 reference

Chung Kil Song

1

1 reference

17 September 2017

Hee Dong Han

2

1 reference

17 September 2017

Kyung Hee Noh

3

1 reference

17 September 2017

Tae Heung Kang

4

1 reference

17 September 2017

Yong Sung Park

5

1 reference

17 September 2017

Jin Hee Kim

6

1 reference

17 September 2017

Eun Suk Park

7

1 reference

17 September 2017

Byung Cheol Shin

8

1 reference

17 September 2017

Tae Woo Kim

9

1 reference

17 September 2017

publication date

5 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

15

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

1558-1563

1 reference

Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Low-dose vaccinia virus-mediated cytokine gene therapy of glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Comparison of HPV DNA vaccines employing intracellular targeting strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Immunotherapy and chemotherapy--a practical partnership

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Combined chemoimmunotherapy of solid tumours: improving vaccines?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL re

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300221

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300221

1 reference

17 September 2017

1 reference